[Federal Register Volume 61, Number 115 (Thursday, June 13, 1996)] [Notices] [Page 30089] From the Federal Register Online via the Government Publishing Office [www.gpo.gov] [FR Doc No: 96-15056] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES National Heart, Lung, and Blood Institute; Notice of Closed Meeting Pursuant to Section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following Heart, Lung, and Blood Special Emphasis Panel (SEP) meeting: Name of SEP: Sickle Cell Disease Therapy. Date: June 20-21, 1996. Time: 7:30 p.m. Place: Holiday Inn, Chevy Chase, 5522 Wisconsin Avenue, Chevy Chase, Maryland 20815. Contact Person: Ivan Baines, Ph.D., Two Rockledge Center, Room 7184, 6701 Rockledge Drive, Bethesda, MD 20892-7924, (301) 435-0277. Purpose/Agenda: To review and evaluate grant applications. The meeting will be closed in accordance with the provisions set forth in secs. 552b(c)(4) and 552b(c)(6), Title 5, U.S.C. Applications and/or proposals and the discussions could reveal confidential trade secrets or commercial property such as patentable material and personal information concerning individuals associated with the applications and/or proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. This notice is being published less than fifteen days prior to the meeting due to the urgent need to meet timing limitations imposed by the review and funding cycle. (Catalog of Federal Domestic Assistance Programs Nos. 93.837, Heart and Vascular Diseases Research; 93.838, Lung Diseases Research; and 93.839, Blood Diseases and Resources Research, National Institutes of Health) Dated: June 10, 1996. Susan K. Feldman, Committee Management Officer, NIH. [FR Doc. 96-15056 Filed 6-12-96; 8:45 am] BILLING CODE 4140-01-M